Megatrend instead of fleeting trend: Biogena rides the longevity wave
The stock-listed producer of dietary supplements wants to more than triple its sales by the 2030/31 financial year. But how?
We haven't written up this one. Der Standard Wirtschaft has the full story — the link below goes straight to it.